Filed by Applera Corporation

Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934

Subject Company: Axys Pharmaceuticals, Inc.
Commission File No. 000-22788

        Attached are the slides that were shown as part of the June 26, 2001 presentation by Peter Chambré, Chief Operating Officer of Applera Corporation, at the 21^st Annual Growth Stock Conference hosted by William Blair & Company. The text of the transcription of Mr. Chambré’s presentation was filed with the Securities and Exchange Commission in a separate Rule 425 filing on June 28, 2001.